Population Genetics Gets Funding under International Leukemia Study | GenomeWeb

NEW YORK (GenomeWeb News) – Population Genetics said today that it has received funding to support a European-backed international research consortium studying genetic risk among children for relapse of acute lymphoblastic leukemia, or ALL.

Funded with €6 million ($7.5 million) from the European Commission, the five-year effort, called the IntReALL consortium, will engage 23 research teams seeking to develop a standardized treatment for this malignant childhood disease, an effort that will involve gathering, banking, and studying DNA from Europe, Japan, Israel, and Australia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.

Oct
13
Sponsored by
Personal Genome Diagnostics

This online seminar will discuss sample collection challenges associated with tumor sequencing, with a particular focus on somatic variant testing in plasma.